Considering these data, we chose to investigate EGFR regulation in NSCLC line H292 as H292 is devoid of any EGFR or KRAS mutations and as such, is a suitable representative of wild type patients representing the majority of NSCLC cases. This evidence concerns the gene EGFR and non-small cell lung carcinoma.